To assess the role of miRNA expression in relation to clinical outcome, the expression levels of 18 miRNAs targeting KRAS were determined by real-time RT-PCR in 32 primary colorectal tumours relative to their matched normal tissue. This evidence concerns the gene KRAS and colorectal neoplasm.